A group of direct purchasers sued Cephalon, Mylan, Teva and Ranbaxy Laboratories in 2006 for so-called “pay-for-delay†settlements in which brand-name drug makers pay their generic counterparts to keep drugs off the market.Sun Pharma settles Modafinil antitrust litigation with certain US plaintiffs
A group of direct purchasers sued Cephalon, Mylan, Teva and Ranbaxy Laboratories in 2006 for so-called “pay-for-delay†settlements in which brand-name drug makers pay their generic counterparts to keep drugs off the market.
Subscribe to:
Post Comments (Atom)
-
"The (latest) investment will be used to grow the mobile esports format and establish presence in select overseas markets through its ...
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment